Publications

Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Pedrosa, Pedro, Amelie Heuer-Jungemann, Antonios G. Kanaras, Alexandra R. Fernandes, and Pedro V. Baptista. "Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles." Journal of Nanobiotechnology 15 (2017). Abstract

n/a

Restani, Rita B., Rita F. Pires, Anna Tolmatcheva, Rita Cabral, V. Baptista, Pedro, Alexandra R. Fernandes, Teresa Casimiro, Vasco D. B. Bonifacio, and Ana Aguiar-Ricardo. "POxylated Dendrimer-Based Nano-in-Micro Dry Powder Formulations for Inhalation Chemotherapy." Chemistryopen 7 (2018): 772-779. Abstract

n/a

Restani, Rita B., Joao Conde, Rita F. Pires, Pedro Martins, Alexandra R. Fernandes, Pedro V. Baptista, and Vasco D. B. Bonifacio. "POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50 Lowering Capacity." MACROMOLECULAR BIOSCIENCE 15 (2015): 1045-1051. AbstractWebsite

The design and preparation of highly efficient drug delivery platforms using green methodologies is at the forefront of nanotherapeutics research. POxylated polyurea dendrimers are efficiently synthesized using a supercritical-assisted polymerization in carbon dioxide. These fluorescent, pH-responsive and water-soluble core-shell smart nanocarriers show low toxicity in terms of cell viability and absence of glutathione depletion, two of the major side effect limitations of current vectors. The materials are also found to act as good transfection agents, through a mechanism involving an endosomal pathway, being able to reduce 100-fold the IC50 of paclitaxel.

Baptista, Pedro Viana. "Precision nanomedicine in cancer: how far are we from personalization?" Expert Review of Precision Medicine and Drug Development 1 (2016): 227-228. Abstract

n/a

Baptista, Pedro Viana. "Principles in genetic risk assessment." THERAPEUTICS AND CLINICAL RISK MANAGEMENT 1 (2005): 15-20. AbstractWebsite

Risk assessment constitutes an essential component of genetic counseling and testing, and the genetic risk should be estimated as accurately as possible for individual and family decision making. All relevant information retrieved from population studies and pedigree and genetic testing enhances the accuracy of the assessment of an individual’s genetic risk. This review will focus on the following general aspects implicated in risk assessment: the increasing genetic information regarding disease; complex traits versus Mendelian disorders; and the influence of the environment and disease susceptibility. The influence of these factors on risk assessment will be discussed.

Bao, Chenchen, Joao Conde, Ester Polo, Pablo del Pino, Maria Moros, Pedro V. Baptista, Valeria Grazu, Daxiang Cui, and Jesus M. de la Fuente. "A promising road with challenges: where are gold nanoparticles in translational research?" Nanomedicine 9 (2014): 2353-2370. Abstract

n/a

Q
Veigas, Bruno, Joana Pinto, Raquel Vinhas, Tomas Calmeiro, Rodrigo Martins, Elvira Fortunato, and Pedro Viana Baptista. "Quantitative real-time monitoring of RCA amplification of cancer biomarkers mediated by a flexible ion sensitive platform." Biosensors & Bioelectronics 91 (2017): 788-795. Abstract

n/a

R
Branquinho, R., B. Veigas, J. V. Pinto, R. Martins, E. Fortunato, and P. V. Baptista. "Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta₂O₅ electrolyte-insulator-semiconductor sensor." Biosens Bioelectron 28 (2011): 44-9. AbstractWebsite

n/a

Conde, Joao, Jorge T. Dias, Valeria Grazu, Maria Moros, Pedro V. Baptista, and Jesus M. de la Fuente. "Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine." Frontiers in Chemistry 2 (2014). Abstract

n/a

Conde, João, Jesús M. de la Fuente, and Pedro V. Baptista. "RNA quantification using gold nanoprobes - application to cancer diagnostics." J. Nanobiotechnology 8 (2010): 5.
Baptista, Pedro V. "RNA quantification with gold nanoprobes for cancer diagnostics." Clinics in Laboratory Medicine 32 (2012): 1-13.
Conde, Joao, Furong Tian, Yulan Hernandez, Chenchen Bao, Pedro V. Baptista, Daxiang Cui, Tobias Stoeger, and Jesus M. de la Fuente. "RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing." Nanoscale 7 (2015): 9083-9091. Abstract

n/a

S
Veigas, Bruno, Carla Portugal, Rita Valerio, Elvira Fortunato, Joao G. Crespo, and Pedro V. Baptista. "Scalable approach for the production of functional DNA based gold nanoprobes." Journal of Membrane Science 492 (2015): 528-535. Abstract

n/a

McCully, Mark, Yulan Hernandez, João Conde, Pedro V. Baptista, Jesus M. de la Fuente, Andrew Hursthouse, and David St. "The significance of the balance between intracellular glutathione and polyethylene glycol (PEG) for successful siRNA release from gold nanoparticles." Nano Research (2015). AbstractWebsite

The therapeutic promise of small interfering RNAs (siRNAs) for specific gene silencing is dependent on the
successful delivery of functional siRNAs to the cell cytoplasm. Their conjugation to an established delivery
platform, such as gold nanoparticles, offers a huge potential for treating diseases and advancing our
understanding of cellular processes. The success or failure is dependent on both the uptake of the nanoparticlesinto the cells and subsequent intracellular release of the functional siRNA. In this paper, utilising gold nanoparticle siRNA-mediated delivery against C-MYC, we aimed to determine if we could achieve knockdown in a cancer cell line with low levels of intracellular glutathione, and determine the influence, if any, of polyethylene glycol (PEG) ligand density on knockdown, with a view to determine the optimal nanoparticle
design to achieve C-MYC knockdown. We demonstrate that, regardless of the PEG density, knockdown in cells with relatively low glutathione levels can be achieved, and also the possible effect of steric hindrance in terms of PEG on the availability of the siRNA for cleavage in the intracellular environment. Gold nanoparticle uptake was demonstrated via transmission electron microscopy and mass spectroscopy, whilst knockdown was determined at the protein and physiological levels (cells in S-phase) by in-cell westerns and BrdU incorporation, respectively.

McCully, Mark, Yulan Hernandez, Joao Conde, Pedro V. Baptista, Jesus M. de la Fuente, Andrew Hursthouse, David Stirling, and Catherine C. Berry. "Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles." Nano Research 8 (2015): 3281-3292. Abstract

n/a

Bernacka-Wojcik, Iwona, Hugo Aguas, Fabio Ferreira Carlos, Paulo Lopes, Pawel Jerzy Wojcik, Mafalda Nascimento Costa, Bruno Veigas, Rui Igreja, Elvira Fortunato, Pedro Viana Baptista, and Rodrigo Martins. "Single Nucleotide Polymorphism Detection Using Gold Nanoprobes and Bio-Microfluidic Platform With Embedded Micro lenses." Biotechnology and Bioengineering 112 (2015): 1210-1219. Abstract

n/a

Roma-Rodrigues, Catarina, Francisca Pereira, Antonio P. Alves de Matos, Marta Fernandes, Pedro V. Baptista, and Alexandra R. Fernandes. "Smuggling gold nanoparticles across cell types - A new role for exosomes in gene silencing." Nanomedicine-Nanotechnology Biology and Medicine 13 (2017): 1389-1398. Abstract

n/a

Quaresma, Pedro, Ines Osorio, Goncalo Doria, Patricia A. Carvalho, Andre Pereira, Judith Langer, Joao Pedro Araujo, Isabel Pastoriza-Santos, Luis M. Liz-Marzan, Ricardo Franco, Pedro V. Baptista, and Eulalia Pereira. "Star-shaped magnetite@gold nanoparticles for protein magnetic separation and SERS detection." Rsc Advances 4 (2014): 3659-3667. AbstractWebsite

n/a

Das, Kuheli, Amitabha Datta, Chiara Massera, Catarina Roma-Rodrigues, Mariana Barroso, Pedro V. Baptista, and Alexandra R. Fernandes. "Structural aspects of a trimetallic CuII derivative: cytotoxicity and anti-proliferative activity on human cancer cell lines." Journal of Coordination Chemistry 72 (2019): 920-940. AbstractWebsite

n/a

Almeida, J., C. Roma-Rodrigues, A. G. Mahmoud, M. F. C. Guedes da Silva, A. J. L. Pombeiro, D.RS L. M. Martins, P. V. Baptista, and A. R. Fernandes. "Structural characterization and biological properties of silver(I) tris(pyrazolyl)methane sulfonate." J Inorg Biochem 199 (2019): 110789. AbstractWebsite

n/a

Roma-Rodrigues, C., G. Malta, D. Peixoto, LM Ferreira, P. V. Baptista, A. R. Fernandes, and P. S. Branco. "Synthesis of new hetero-arylidene-9(10H)-anthrone derivatives and their biological evaluation." Bioorg Chem 99 (2020): 103849. AbstractWebsite

n/a

Ma, Zhen, Bian Zhang, Fátima Guedes M. C. da Silva, Joana Silva, Ana Soraia Mendo, Pedro Viana Baptista, and Alexandra R. Fernandes. "Synthesis, Characterization, Thermal Properties and Antiproliferative Potential of Copper(II) 4′-phenyl-terpyridine Compounds." Dalton Transactions 45 (2016).
Daniela, Peixoto, Figueiredo Margarida, Malta Gabriela, Roma‐Rodrigues Catarina, Baptista Pedro V., Fernandes Alexandra R., Barroso Sónia, Carvalho Ana Luísa, Afonso Carlos A. M., Ferreira Luisa M., and Branco Paula S. "Synthesis, Cytotoxicity Evaluation in Human Cell Lines and in Vitro DNA Interaction of a Hetero‐Arylidene‐9(10H)‐Anthrone." European Journal of Organic ChemistryEuropean Journal of Organic Chemistry 2018 (2018): 545-549. AbstractWebsite

A new and never before reported hetero?arylidene?9(10H)?anthrone structure (4) was unexpectedly isolated on reaction of 1,2?dimethyl?3?ethylimidazolium iodide (2) and 9?anthracenecarboxaldehyde (3) under basic conditions. Its structure was unequivocally confirmed by X?ray crystallography. No cytotoxicity in human healthy fibroblasts and in two different cancer cell lines was observed, indicating its applicability in biological systems. Compound 4 interacts with CT?DNA by intercalation between the adjacent base pairs of DNA with a high binding affinity [Kb = 2.0?(±0.20)???105 m?1], which is 10?? higher than that described for doxorubicin [Kb = 3.2?(±0.23)???104 m?1]. Furthermore, compound 4 quenches the fluorescence emission of a GelRed?CT?DNA system with a quenching constant (KSV) of 3.3?(±0.3)???103 m?1 calculated by the Stern?Volmer equation.

T
Alves-Barroco, C., L. Rivas-García, A. R. Fernandes, and P. V. Baptista. "Tackling Multidrug Resistance in Streptococci - From Novel Biotherapeutic Strategies to Nanomedicines." Front Microbiol 11 (2020): 579916. AbstractWebsite

n/a